Dyne Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for genetically driven neuromuscular diseases. The company utilizes its proprietary FORCE pla... Dyne Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for genetically driven neuromuscular diseases. The company utilizes its proprietary FORCE platform to deliver targeted RNA therapies designed to overcome delivery limitations to muscle tissue and the central nervous system. Dyne's lead programs address significant unmet medical needs in conditions including myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company is advancing multiple candidates through clinical development, with key programs progressing toward regulatory milestones and potential commercialization. Dyne operates in the rare disease biotechnology space, serving patients with limited treatment options and positioning itself for potential market entry as its pipeline candidates mature toward approval and launch.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Dyne Therapeutics

We have not yet reviewed Dyne Therapeutics's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Dyne Therapeutics's data?

Start your 30-day free trial to request a data review for Dyne Therapeutics.

Start Free Trial

Legal Center Contact Us

Dyne Therapeutics, Inc

Group Entities data not yet covered for Dyne Therapeutics

Account Restricted